Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Non-cash Items (2017 - 2025)

iBio (IBIO) has disclosed Non-cash Items for 11 consecutive years, with $228502.0 as the latest value for Q2 2025.

  • On a quarterly basis, Non-cash Items rose 3431.17% to $228502.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $228502.0, a 3431.17% increase, with the full-year FY2025 number at $228502.0, down 18.39% from a year prior.
  • Non-cash Items was $228502.0 for Q2 2025 at iBio, up from $6471.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $2.0 million in Q2 2021 to a low of $4790.0 in Q2 2023.
  • A 5-year average of $486433.4 and a median of $197404.0 in 2022 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: tumbled 97.57% in 2023, then soared 3431.17% in 2025.
  • iBio's Non-cash Items stood at $2.0 million in 2021, then crashed by 90.11% to $197404.0 in 2022, then crashed by 97.57% to $4790.0 in 2023, then surged by 35.09% to $6471.0 in 2024, then skyrocketed by 3431.17% to $228502.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Non-cash Items are $228502.0 (Q2 2025), $6471.0 (Q2 2024), and $4790.0 (Q2 2023).